Search Prime Grants

U24HG012198

Cooperative Agreement

Overview

Grant Description
Reactome: an open knowledgebase of human pathways.
Awardee
Ontario Institute For Cancer Research Institut Ontarien De Recherche Sur Le Cancer
Funding Goals
NHGRI SUPPORTS THE DEVELOPMENT OF RESOURCES AND TECHNOLOGIES THAT WILL ACCELERATE GENOME RESEARCH AND ITS APPLICATION TO HUMAN HEALTH AND GENOMIC MEDICINE. A CRITICAL PART OF THE NHGRI MISSION CONTINUES TO BE THE STUDY OF THE ETHICAL, LEGAL AND SOCIAL IMPLICATIONS (ELSI) OF GENOME RESEARCH. NHGRI ALSO SUPPORTS THE TRAINING AND CAREER DEVELOPMENT OF INVESTIGATORS AND THE DISSEMINATION OF GENOME INFORMATION TO THE PUBLIC AND TO HEALTH PROFESSIONALS. THE SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM IS USED TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. THE SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM IS USED TO FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
93.172 - Human Genome Research
Awarding / Funding Agency
National Human Genome Research Institute (NHGRI) [HHS - NIH]
Place of Performance
Canada
Geographic Scope
Foreign
Related Opportunity
Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed) (PAR-20-097)
Analysis Notes
Amendment Since initial award the total obligations have increased 283% from $1,461,197 to $5,597,521.
Ontario Institute For Cancer Research Institut Ontarien De Recherche Sur Le Cancer was awarded Reactome: An Open Knowledgebase of Human Pathways. Cooperative Agreement U24HG012198 worth $5,597,521 from National Human Genome Research Institute in August 2022 with work to be completed primarily in Canada. The grant has a duration of 4 years 9 months and was awarded through assistance program 93.172 Human Genome Research. The Cooperative Agreement was awarded through grant opportunity Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed).

Status
(Ongoing)

Last Modified 9/26/25

Period of Performance
8/18/22
Start Date
5/31/27
End Date
68.0% Complete

Funding Split
$5.6M
Federal Obligation
$0.0
Non-Federal Obligation
$5.6M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U24HG012198

Transaction History

Modifications to U24HG012198

Additional Detail

Award ID FAIN
U24HG012198
SAI Number
U24HG012198-1480526241
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Non-Domestic (Non-U.S.) Entity
Awarding Office
75N400 NIH National Human Genome Research Institute
Funding Office
75N400 NIH National Human Genome Research Institute
Awardee UEI
LH6LETZC1CJ5
Awardee CAGE
L8268
Performance District
Not Applicable

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Human Genome Research Institute, National Institutes of Health, Health and Human Services (075-0891) Health research and training Grants, subsidies, and contributions (41.0) $3,063,191 92%
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) Health research and training Grants, subsidies, and contributions (41.0) $268,201 8%
Modified: 9/26/25